首页> 美国卫生研究院文献>Critical Care >Pro/con clinical debate: pulmonary artery catheters increase the morbidity and mortality of intensive care unit patients
【2h】

Pro/con clinical debate: pulmonary artery catheters increase the morbidity and mortality of intensive care unit patients

机译:Pro / con临床辩论:肺动脉导管增加了重症监护病房患者的发病率和死亡率

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

One of the highlights of the intensive care unit when I was a resident was the opportunity to place a pulmonary artery catheter and then spend the rest of the day calculating parameters such as oxygen delivery, oxygen consumption, intrapulmonary shunt fraction, and so on. I have noticed in the past few years that the use of these devices in our unit is much less frequent. In our case I am not absolutely certain of the reason for this. Perhaps with time our clinical sense has improved to the point that we do not need the data available, perhaps other tests have replaced the pulmonary artery catheter's role or perhaps we are worried about the possible morbidity/mortality associated with its use. In the present article, we revisit this important debate.
机译:当我住院时,重症监护病房的一大亮点是有机会放置肺动脉导管,然后在一天的剩余时间里花时间计算参数,例如氧气输送,氧气消耗,肺内分流分数等。过去几年中,我注意到在我们的设备中使用这些设备的频率要低得多。在我们的情况下,我不确定这个原因。也许随着时间的流逝,我们的临床感觉已经改善到我们不需要可用数据的地步,也许其他测试取代了肺动脉导管的作用,或者也许我们担心与其使用相关的发病率/死亡率。在本文中,我们将重新讨论这一重要辩论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号